Radiometer logo

COVID-19 pandemic

The essential role of clinical biochemistry

A wide range of clinical diagnostics play an essential role in the fight against the coronavirus disease 2019 (COVID-19) pandemic.

Although hematology and biochemistry tests cannot diagnose SARS-CoV-2 infection, they are used in several aspects of the COVID-19 care pathway. These include supporting patient management and risk stratification, as well as helping to identify the development of potential complications in diagnosed patients. [1] 

Furthermore, digital solutions that enable remote maintenance of point-of-care testing devices in COVID-19 units can support the work of healthcare professionals and frontline staff. [2]

1. Thompson et al. IFCC interim guidelines on biochemical/hematological monitoring of COVID-19 patients. Clinical Chemistry and Laboratory Medicine. 2020;58(12):2009-2016.
2. Nair et al. Guidance for use of point of care testing equipment in positive patients and those with a suspected diagnosis of COVID-19 (G204). The Royal College of Pathologists. March 2020.

D-dimer and procalcitonin in summary

This summary of two scientific papers suggests that D-dimer and procalcitonin testing may be used to help assess comorbidities in patients hospitalized with COVID-19.

COVID-19 pandemic — the tide is turning

In this article, Jacob de Haan discusses the emerge of a pandemic, the current understanding of the disease and the virus, how to manage patients diagnosed with COVID-19.

Laboratory testing is critical

Radiometer Medical General Manager for India & South Asia, Smit Dave, discusses the role of clinical diagnostics during the COVID-19 pandemic.

The value of D-dimer

In this webinar, Radiometer’s global immunoassay expert, Guillaume Galpy, explains the concept and value of the D-dimer biomarker.

Point-of-care testing during the COVID-19 pandemic

Watch as Dr. Nam Tran reviews the effects of COVID-19 on POCT workflows and discusses COVID-19 best practices from the perspective of clinical chemistry.

Delivering effective POCT during COVID-19

Listen to Katy Heaney, POCT Speciality Lead, as she discusses the impact of COVID-19 on POCT services and how POCT services will evolve post COVID-19.
Radiometer in the Emergency Department - Hospital situation with patient

Speed up patient flow in the ED

Point-of-care testing can help to reduce turnaround times and accelerate patient flow.

Fast results in the ICU

When ICUs are overrun, you need fast test results at the point of care.

Keep analyzers up and running

Remote monitoring and troubleshooting can support analyzer uptime.

MAPSSS-000459 R3

Cookies are used on this website

Use of cookies
Confirm your account with Radiometer

Please enter a valid email

By submitting your e-mail you agree to the data policy notice
Radiometer is using Microsoft Azure Active Directory to authenticate customer access. If you are already registered you will be taken to Microsoft AD to sign in using your Microsoft AD credentials.
You are already registered
Radiometer is using Microsoft Azure AD to authenticate customer access. If you are already registered you will be taken to AZURE to sign in using your AZURE credentials.
Thank you

We will be sending an e-mail invitation to you shortly to sign in using Microsoft Azure AD.

Radiometer is using Microsoft Azure AD to authenticate customer access.

It seems that your e-mail is not registered with us

Radiometer is using Microsoft Azure AD to authenticate customer access. If your e-mail is not registered with us please click CONTINUE and we will guide you through the sign-in process.
We have previously sent an invitation by e-mail

Please click "Get started" in the e-mail to complete the registration process

Radiometer is using Microsoft Azure AD to authenticate customer access.

We were not able to process your request due to a communication error


It seems this account has not been given access to the portal

Radiometer is using Microsoft AZURE Active Directory to authenticate users

Radiometer uses Azure AD to provide our customers and partners secure access to documents, resources, and other services on our customer portal.

If your organization is already using Azure AD you can use the same credentials to access Radiometer's customer portal.

Key benefits

  • Allow the use of existing Active Directory credentials
  • Single-sign on experience
  • Use same credentials to access future services

Request access

You will receive an invitation to access our services via e-mail when your request has been approved.

When you accept the invitation, and your organization is already using AZURE AD, you can use the same credentials to access Radiometer's customer portal. Otherwise, a one-time password will be sent via e-mail to sign in.

Effective Date January 20th, 2023 (last updated January 20th, 2023)


Radiometer values your privacy and the protection of your personal data. This policy (“Policy”) explains how Radiometer its affiliates, subsidiaries or related companies, a full list of which can be located here (together, “Radiometer”, “our”, “us”, or “we”), collects, uses, shares, transfers and processes data collected from or about you.

Personal Data” is any information that can be used to directly or indirectly identify an individual or that can be reasonably expected to link to an individual. This can include items such as name, address, telephone number, credit card details, email address, ID number, Internet Protocol (“IP”) address of an electronic device used by an individual, or other identifying code (even absent of other identifying information). Statistical and non-identifiable metric data are not considered Personal Data.

The Radiometer subsidiary, affiliate or related company with which you interact is, where applicable, the data controller (or equivalent under applicable law) responsible for the processing of your Personal Data. You can find a list of the relevant legal entities that act as data controllers in Appendix 1 to this Policy.


This Policy describes the types of Personal Data that we may collect, process or disclose about you and how you may govern this processing by exercising applicable legal rights. This Policy applies to both online and offline information collection, including your use of websites or subdomains operated by us, any mobile applications, when we provide products and/or services to you or notify you about prospective items of interest and in other situations where you interact with us in-person, by telephone or by mail where this Policy is posted or referenced.

There may be occasion where you have been provided with a circumstance-specific privacy notice that is separate from this policy, such as privacy notices for specific activities such as Recruitment. To the extent you were provided with a different notice, those notices apply and govern our interactions with you. If you provide Personal Data about parties other than yourself, you are responsible for ensuring their knowledge of how we will process their personal data, and, where applicable, obtaining any necessary consents required in advance.

We are committed to processing Personal Data in accordance with applicable laws. Please note that if you do not wish to provide your Personal Data to us, some products and/or services may become unavailable to you. Your use of any or all these platforms indicates you have been notified of our collection, use, transfer, and disclosure of your information as described in this Policy to the extent permitted by applicable law.

Read more